,40 To determine the role of CD4+ T cells on the activity of anti-CTLA4 therapy against idMMR neuroblastoma tumors, we depleted these cells in immunocompetent animals before the treatment of idMMR tumor-bearing mice with anti-CTLA4 antibody (Figure 6A). This evidence concerns the gene CD4 and neuroblastoma.